AQR Arbitrage’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-82,193
| Closed | -$1.04M | – | 419 |
|
|
2025
Q1 | $1.04M | Sell |
82,193
-106,232
| -56% | -$1.35M | 0.02% | 227 |
|
|
2024
Q4 | $2.47M | Sell |
188,425
-74,853
| -28% | -$982K | 0.05% | 218 |
|
|
2024
Q3 | $3.97M | Sell |
263,278
-73,922
| -22% | -$1.11M | 0.09% | 193 |
|
|
2024
Q2 | $4.78M | Sell |
337,200
-50,110
| -13% | -$710K | 0.12% | 166 |
|
|
2024
Q1 | $5.28M | Buy |
387,310
+3,079
| +0.8% | +$42K | 0.18% | 131 |
|
|
2023
Q4 | $5.17M | Buy |
384,231
+111,735
| +41% | +$1.5M | 0.21% | 126 |
|
|
2023
Q3 | $3.4M | Buy |
272,496
+128,933
| +90% | +$1.61M | 0.15% | 160 |
|
|
2023
Q2 | $1.94M | Buy |
143,563
+49,864
| +53% | +$675K | 0.08% | 257 |
|
|
2023
Q1 | $1.31M | Buy |
93,699
+39,988
| +74% | +$557K | 0.04% | 392 |
|
|
2022
Q4 | $763K | Buy |
53,711
+43,681
| +436% | +$621K | 0.02% | 550 |
|
|
2022
Q3 | $137K | Buy |
+10,030
| New | +$137K | ﹤0.01% | 787 |
|
|
2021
Q1 | – | Sell |
-58,795
| Closed | -$1.16M | – | 1157 |
|
|
2020
Q4 | $1.16M | Sell |
58,795
-10,876
| -16% | -$215K | 0.04% | 390 |
|
|
2020
Q3 | $1.23M | Buy |
69,671
+18,073
| +35% | +$318K | 0.04% | 280 |
|
|
2020
Q2 | $927K | Buy |
51,598
+22,690
| +78% | +$408K | 0.04% | 294 |
|
|
2020
Q1 | $433K | Buy |
28,908
+16,124
| +126% | +$242K | 0.01% | 353 |
|
|
2019
Q4 | $223K | Hold |
12,784
| – | – | ﹤0.01% | 406 |
|
|
2019
Q3 | $193K | Buy |
+12,784
| New | +$193K | ﹤0.01% | 404 |
|